Hanley; Michael R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hanley; Michael R..The latest application filed is for "hybrid polypeptides with selectable properties".

Company Profile

0.21.25

Hanley; Michael R. - Corte Madera CA
Hanley; Michael R. - San Diego CA
Hanley; Michael R. - Corte Madero CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hybrid polypeptides with selectable properties Grant 9,453,063 - Levy , et al. September 27, 2	2016-09-27
GIP analog and hybrid polypeptides with selectable properties Grant 9,133,260 - Levy , et al. September 15, 2	2015-09-15
GIP and exendin hybrid polypeptides Grant 8,895,498 - Levy , et al. November 25, 2	2014-11-25
Hybrid Polypeptides With Selectable Properties App 20140249299 - Levy; Odile Esther ; et al.	2014-09-04
Hybrid polypeptides with selectable properties Grant 8,697,647 - Levy , et al. April 15, 2	2014-04-15
Methods for treatment using amylin family peptides Grant 8,598,120 - Soares , et al. December 3, 2	2013-12-03
Dpp-iv Resistant Gip Hybrid Polypeptides With Selectable Properties App 20130281374 - Levy; Odile Esther ; et al.	2013-10-24
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20130196913 - Levy; Odile Esther ; et al.	2013-08-01
DPP-IV resistant GIP hybrid polypeptides with selectable properties Grant 8,497,240 - Levy , et al. July 30, 2	2013-07-30
Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders App 20130184213 - LAUGERO; Kevin D. ; et al.	2013-07-18
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20130137631 - LEVY; Odile Esther ; et al.	2013-05-30
GIP analog and hybrid polypeptides with selectable properties Grant 8,404,637 - Levy , et al. March 26, 2	2013-03-26
Amylin and amylin agonists for treating psychiatric diseases and disorders Grant 8,389,477 - Laugero , et al. March 5, 2	2013-03-05
Neuromedin and FN-38 Peptides for Psychotic Diseases App 20130035294 - Laugero; Kevin D. ; et al.	2013-02-07
Neuromedin and FN-38 peptides for treating psychiatric diseases Grant 8,309,522 - Laugero , et al. November 13, 2	2012-11-13
Hybrid Polypeptides With Selectable Properties App 20120253023 - LEVY; Odile Esther ; et al.	2012-10-04
GIP analog and hybrid polypeptides with selectable properties Grant 8,263,545 - Levy , et al. September 11, 2	2012-09-11
Amylin Family Peptides And Methods For Making And Using Them App 20120196796 - Soares; Christopher J. ; et al.	2012-08-02
Amylin family peptides Grant 8,114,958 - Soares , et al. February 14, 2	2012-02-14
Hybrid polypeptides having glucose lowering activity Grant 8,076,288 - Levy , et al. December 13, 2	2011-12-13
Amylin And Amylin Agonists For Treating Psychiatric Diseases And Disorders App 20110288028 - Laugero; Kevin D. ; et al.	2011-11-24
DPP-IV Resistant GIP Hybrid Polypeptides with Selectable Properties App 20110136737 - Levy; Odile Esther ; et al.	2011-06-09
Neuromedin and FN-38 Peptides for Treating Psychiatric Diseases App 20100168013 - Laugero; Kevin D. ; et al.	2010-07-01
Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders App 20100125054 - Laugero; Kevin D. ; et al.	2010-05-20
Amylin agonist for treating depression, anxiety disorder and schizophrenia Grant 7,671,023 - Laugero , et al. March 2, 2	2010-03-02
Hybrid Polypeptides with Selectable Properties App 20090286723 - Levy; Odile Esther ; et al.	2009-11-19
Analogues of lipid mediators derived from .omega.-3 PUFAs and methods of use Grant 7,595,341 - Goodman , et al. September 29, 2	2009-09-29
Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders App 20090181890 - Laugero; Kevin D. ; et al.	2009-07-16
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20090036364 - Levy; Odile Esther ; et al.	2009-02-05
Gip Analog And Hybrid Polypeptides With Selectable Properties App 20080312157 - Levy; Odile Esther ; et al.	2008-12-18
Amylin and Amylin Agonists For Treating Psychiatric Diseases and Disorders App 20080287355 - Laugero; Kevin D. ; et al.	2008-11-20
Amylin Family Peptides And Methods For Making And Using Them App 20080274952 - Soares; Christopher J ; et al.	2008-11-06
Analogues of lipid mediators derived from omega-3 PUFAs and methods of use App 20080207753 - Goodman; Daniel W. ; et al.	2008-08-28
Analogues of lipid mediators derived from omega-3 PUFAs and methods of use Grant 7,378,444 - Goodman , et al. May 27, 2	2008-05-27
Hybrid polypeptides with selectable properties App 20060293232 - Levy; Odile Esther ; et al.	2006-12-28
Hybrid polypeptides with selectable properties App 20060094652 - Levy; Odile Esther ; et al.	2006-05-04
Analogues of lipid mediators derived from omega-3 PUFAs and methods of use App 20040044050 - Goodman, Daniel W. ; et al.	2004-03-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.